444 related articles for article (PubMed ID: 16763588)
1. Public biotechnology 2005--the numbers.
Lähteenmäki R; Lawrence S
Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
[TBL] [Abstract][Full Text] [Related]
2. Public biotech 2006 - the numbers.
Lähteenmäki R; Lawrence S
Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
[No Abstract] [Full Text] [Related]
3. State of biotech sector--2005.
Lawrence S
Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
[No Abstract] [Full Text] [Related]
4. Private biotech 2004--the numbers.
Hodgson J
Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
[TBL] [Abstract][Full Text] [Related]
5. Public biotech 2010--the numbers.
Huggett B; Hodgson J; Lähteenmäki R
Nat Biotechnol; 2011 Jul; 29(7):585-91. PubMed ID: 21747381
[No Abstract] [Full Text] [Related]
6. Wrong numbers?
Nat Biotechnol; 2010 Aug; 28(8):761. PubMed ID: 20697382
[No Abstract] [Full Text] [Related]
7. Public biotechnology 2002--the numbers.
Lähteenmäki R; DeFrancesco L
Nat Biotechnol; 2003 Jun; 21(6):607-12. PubMed ID: 12776143
[No Abstract] [Full Text] [Related]
8. Insights into US public biotech sector using patenting trends.
Aggarwal S; Gupta V; Bagchi-Sen S
Nat Biotechnol; 2006 Jun; 24(6):643-51. PubMed ID: 16763590
[TBL] [Abstract][Full Text] [Related]
9. Public biotech 2009-the numbers.
Huggett B; Hodgson J; Lähteenmäki R
Nat Biotechnol; 2010 Aug; 28(8):793-9. PubMed ID: 20697401
[No Abstract] [Full Text] [Related]
10. Public biotechnology 2003-the numbers.
Lähteenmäki R; Baker M
Nat Biotechnol; 2004 Jun; 22(6):665-70. PubMed ID: 15175683
[No Abstract] [Full Text] [Related]
11. Public markets show signs of life.
Mitchell P
Nat Biotechnol; 2003 Aug; 21(8):833-4. PubMed ID: 12894181
[No Abstract] [Full Text] [Related]
12. 2007--a banner year for biotech.
Lawrence S
Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162
[No Abstract] [Full Text] [Related]
13. Public biotech 2011--the numbers.
Huggett B; Lähteenmaki R
Nat Biotechnol; 2012 Aug; 30(8):751-7. PubMed ID: 22871710
[No Abstract] [Full Text] [Related]
14. The responsibilities of growing up.
Nat Biotechnol; 2006 Mar; 24(3):225. PubMed ID: 16525362
[No Abstract] [Full Text] [Related]
15. Public biotechnology 2001--the numbers.
Lähteenmäki R; Fletcher L
Nat Biotechnol; 2002 Jun; 20(6):551-5. PubMed ID: 12042853
[No Abstract] [Full Text] [Related]
16. Public biotech 99: the numbers.
Lähteenmäki R; Hodgson J
Nat Biotechnol; 2000 May; 18(5):499-503. PubMed ID: 10802615
[No Abstract] [Full Text] [Related]
17. Public biotech 2013--the numbers.
Lawrence S; Lahteenmaki R
Nat Biotechnol; 2014 Jul; 32(7):626-32. PubMed ID: 25004227
[No Abstract] [Full Text] [Related]
18. Korean biotechs seize opportunity to list on public markets.
Louët S
Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042
[No Abstract] [Full Text] [Related]
19. Biotech patenting slows in 2004.
Lawrence S
Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
[No Abstract] [Full Text] [Related]
20. Biotech R&D still reeling.
Lawrence S
Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
